Skip to main content
Caplight Logo









Omega Ophthalmics

Omega Ophthalmics

Private
Lexington, KentuckyHealthcare & Life Scienceshttps://www.omegaophthalmics.com/

Last Round

Series A

Aug 11, 2026

Total Funding Raised

$9M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Omega Ophthalmics is a medical technology company developing the Gemini Refractive Capsule, a proprietary, surgically implanted lens platform designed to improve outcomes in cataract surgery and provide a stable, biologically integrated platform for intraocular lens implantation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

intraocular lensIOLcataract surgerymedical deviceophthalmologycapsular bagrefractive surgerysurgical implanteye surgerylens exchangeophthalmic innovationvision correction

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omega Ophthalmics Comparables

Compare Omega Ophthalmics with similar companies based on industry and business-model similarity.

Omega Ophthalmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LensGen
80%
Adaptilens
79%
Atia Vision
77%

Omega Ophthalmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 11, 2026
VC RoundJan 15, 2026
VC RoundDec 20, 2024
VC RoundJul 5, 2022
Series AJul 15, 2015

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 94% MoM.

  • Aug 11, 2026

    $7M round completed.

Recent news

Latest coverage and updates

  • receives_financingAug 11, 2026

    Omega Ophthalmics, LLC received financing of $7M in Series A on Aug 11th '26.

Omega Ophthalmics Filings

Explore SEC and related filing metadata, where available.

Omega Ophthalmics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Omega Ophthalmics's valuation, stock price, and market status.

Is Omega Ophthalmics a public or private company?

Omega Ophthalmics is a private company.

What is the current stock price of Omega Ophthalmics?

Omega Ophthalmics is a private company with no public stock price. No recent secondary market data is available.

How much is Omega Ophthalmics worth (valuation)?

Valuation information for Omega Ophthalmics is not publicly available.

Can I buy Omega Ophthalmics stock?

Omega Ophthalmics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Omega Ophthalmics's last funding round?

Omega Ophthalmics's most recent funding round was VC Round on January 15, 2026.

Who are the main investors in Omega Ophthalmics?

Investor information for Omega Ophthalmics is not publicly disclosed.

Will Omega Ophthalmics IPO soon?

No public IPO plans have been announced for Omega Ophthalmics.

How can I track Omega Ophthalmics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Omega Ophthalmics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLexington, Kentucky
Employee Range3
Year Founded2012
Last FundingAug 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?